Covered recipient · General Payments record
JOHN M HATLELID
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,428.01
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $697.91 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $253.54 | 11 |
| Janssen Pharmaceuticals, Inc | $119.77 | 1 |
| Amneal Pharmaceuticals LLC | $117.93 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.68 | 3 |
| ARGENX US, INC. | $38.25 | 2 |
| Abbott Laboratories | $37.38 | 2 |
| Lundbeck LLC | $24.39 | 1 |
| ACADIA Pharmaceuticals Inc | $16.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.88 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895168 | CMS |
| Abbott Laboratories | $17.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895170 | CMS |
| ABBVIE INC. | $16.22 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891623 | CMS |
| ABBVIE INC. | $8.34 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891625 | CMS |
| ABBVIE INC. | $2.23 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891627 | CMS |
| ABBVIE INC. | $8.15 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891629 | CMS |
| ABBVIE INC. | $7.31 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891631 | CMS |
| ABBVIE INC. | $15.62 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891633 | CMS |
| ABBVIE INC. | $30.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891635 | CMS |
| ABBVIE INC. | $12.50 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891637 | CMS |
| ABBVIE INC. | $30.09 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891639 | CMS |
| ABBVIE INC. | $15.06 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891641 | CMS |
| ABBVIE INC. | $107.14 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103891643 | CMS |
| ACADIA Pharmaceuticals Inc | $16.97 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147974459 | CMS |
| Amneal Pharmaceuticals LLC | $117.93 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139188432 | CMS |
| ARGENX US, INC. | $19.59 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142102034 | CMS |
| ARGENX US, INC. | $18.66 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142104213 | CMS |
| Janssen Pharmaceuticals, Inc | $119.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078060434 | CMS |
| Lundbeck LLC | $24.39 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145923816 | CMS |
| Novartis Pharmaceuticals Corporation | $24.01 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086789657 | CMS |
| Novartis Pharmaceuticals Corporation | $35.38 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086789667 | CMS |
| Novartis Pharmaceuticals Corporation | $30.29 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086789673 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.